3D Printing News Roundup: Roboze teams up with Inovsys SAS, Midwest Prototyping receives ISO 9001 certification, more

Jul 12, 2017 | By David

There's been a lot happening in the 3D printing world recently, so it's not been difficult to miss out on something important. Here's a round-up of some recent developments that might have flown under your radar, including Roboze partnering with Inovsys SAS and Midwest Prototyping getting ISO 9001 certification.

Western Tool & Mold adopts Stratasys’ Fortus 900mc technology to 3D print parts for aircraft interiors

3D printing and additive manufacturing solutions expert Stratasys announced recently that its Fortus 900mc Aircraft Interiors (AI) Certification Solution has been adopted by leading parts supplier Western Tool & Mold. The company will be using Stratasys’ technology to produce aircraft cabin components that will be capable of meeting the stringent FAA and EASA certification requirements.

Western Tool & Mold is based in Hong Kong and caters particularly towards the aircraft interiors market, manufacturing toilet parts and overhead lockers, amongst other things. The adoption of 3D printing technology and the consequent acceleration of the manufacturing process means that WTM can test its parts early in the design process, potentially saving hundreds of thousands of dollars.

“Adding the Stratasys Fortus 900mc Aircraft Interiors Certification edition to our extensive arsenal of Stratasys FDM and PolyJet-based 3D Printing Solutions not only gives us the opportunity to provide repeatable, certified aircraft parts to tier 1 and tier 2 aircraft parts suppliers but also the accompanying documentation process is now automated – making it easier to meet evolving industry quality standards while freeing up more time to invest in production,” said Collin Wilkerson, Managing Director, Western Tool & Mold. “The Stratasys Aircraft Interiors Certification Solution will allow us to work with our customers early in their design and development process and help be more agile than our competition in responding to customer requests.”

3D printing company Midwest Prototyping receives ISO 9001 certification

Midwest Protototyping has received the ISO 9001 certification for operational excellence. The company, which is one of the nation’s biggest users of 3D printing technology, is the first independent service bureau to receive this certification. The International Organization for Standardization (ISO) is an independent, non-governmental international organization which develops and publishes International Standards in collaboration with 163 national standards bodies. Its documentation provides guidelines that can be used consistently to ensure that materials, products, processes and services are fit for their purpose.

"For us, obtaining ISO certification is a natural next step," said Steve Grundahl, President and founder of Midwest Prototyping. "As our operations and the additive manufacturing industry have continued to grow, we've seen an increasing number of production and end-use orders for printed parts. This [ISO 9001 certification] is a critical step to create a manufacturing facility for 3D printed, end-use products. If we are going to compete with traditional manufacturing processes, we need to meet them at their level."

Midwest Prototyping has been working for 18 months to get its operations up to the ISO 9001 standard, meeting criteria for customer satisfaction and continuous improvement. The company, which was founded in Wisconsin in 2001, offers multiple 3D printing technologies, urethane casting, and extensive finishing services.

3D printing expert Roboze collaborates with Inovsys SAS to develop new materials for aerospace

Italian 3D printing company Roboze 3D has established a strategic partnership with French company Inovsys SAS. Inovsys provides risk management solutions for companies intending to implement new innovations. The goal of their collaboration will be the development of new advanced materials for the aerospace and medical industries, building on Roboze’s metal replacement materials for 3D printing like PEEK and PEI.

This partnership will be supported by Roboze’s commercial partner Kreos, and is part of the project known as ‘Team Henri-Fabre’. Team Henri Fabre promotes a new industrial development model, one which is more collective and led by innovation and technological opportunities. Its overall goal is the reinforcement of collective innovation and cross-fertilization between different industries, such as aeronautics, space, naval, energy, biomedical, and transportation.

According to Alessio Lorusso, Roboze Founder&CEO, “This collaboration confirms how, once again, our offer is able to support several companies and to foresee new technologies designed to create more advanced systems and applications and to insert them quickly on the market. Thanks to the partnership with Inovsys SAS, as well as in general with Henri-Fabre team, we have the chance to develop advanced production techniques, aimed to deliver the best solutions to our customers in a faster way”.

Histogenics publishes data from collagen and chondrocyte 3D bio-printing study

A peer-reviewed publication entitled Correlating Rheological Properties and Printability of Collagen Bioinks: the Effects of Riboflavin Photocrosslinking and pH was recently published in science journal Bio-fabrication. It detailed research carried out by regenerative company Histogenics Corporation. Histogenics focuses on developing and commercializing products in the musculoskeletal space.

Research detailed in the paper was carried out in collaboration with Dr. Lawrence Bonassar, Professor at Cornell University (Cornell) in the Meinig School of Biomedical Engineering and the Sibley School of Mechanical and Aerospace Engineering. The lead author is Nicole Diamantides of Cornell with support from Louis Wang and Dr. Bonassar of Cornell, Tylar Pruiksma of the University of Utah, and Caroline Dugopolski, Stephen Kennedy, Sonya Shortkroff and Joseph Siemiatkoski of Histogenics.

"Our collaboration with Cornell is an important element of our overall research and development strategy to further characterize the raw materials and cellular therapy platform underlying NeoCart. As a result of the valuable work done under the collaboration, we continue to generate novel, exciting data that we can use to support the optimization of the process used to produce NeoCart, as well as for future development of other product candidates in the NeoCart platform," said Stephen Kennedy, Chief Technology Officer of Histogenics.

NeoCart is a cartilage-like, engineered tissue designed to exhibit characteristics of articular, hyaline cartilage prior to and upon implantation into the knee, which therefore does not rely on the body to make new cartilage. The patient's cells are multiplied in Histogenics' laboratory and then infused into a proprietary scaffold to allow them to organize and function like cartilage cells. Before NeoCart is shipped to the surgeon for implantation, the cell and scaffold construct undergoes a bioengineering process that is designed to mimic a joint so that the implant, upon placement in the knee with a proprietary bio-adhesive that is primed to begin functioning like healthy cartilage. NeoCart is currently in a Phase 3 clinical trial.

Posted in 3D Printer Company

Maybe you also like:

www.3ders.org

3D printer and 3D printing news